| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |